Cargando…

Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin(2) G protein-coupled receptor

The signaling peptides adrenomedullin 2/intermedin (AM2/IMD), adrenomedullin (AM), and CGRP have overlapping and distinct functions in the cardiovascular, lymphatic, and nervous systems by activating three shared receptors comprised of the class B GPCR CLR in complex with a RAMP1, −2, or −3 modulato...

Descripción completa

Detalles Bibliográficos
Autores principales: Babin, Katie M., Karim, Jordan A., Gordon, Peyton H., Lennon, James, Dickson, Alex, Pioszak, Augen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882245/
https://www.ncbi.nlm.nih.gov/pubmed/36711519
http://dx.doi.org/10.1101/2023.01.13.523955
_version_ 1784879261786570752
author Babin, Katie M.
Karim, Jordan A.
Gordon, Peyton H.
Lennon, James
Dickson, Alex
Pioszak, Augen A.
author_facet Babin, Katie M.
Karim, Jordan A.
Gordon, Peyton H.
Lennon, James
Dickson, Alex
Pioszak, Augen A.
author_sort Babin, Katie M.
collection PubMed
description The signaling peptides adrenomedullin 2/intermedin (AM2/IMD), adrenomedullin (AM), and CGRP have overlapping and distinct functions in the cardiovascular, lymphatic, and nervous systems by activating three shared receptors comprised of the class B GPCR CLR in complex with a RAMP1, −2, or −3 modulatory subunit. Here, we report that AM2/IMD, which is thought to be a non-selective agonist, is kinetically selective for CLR-RAMP3, known as the AM(2)R. AM2/IMD-AM(2)R elicited substantially longer duration cAMP signaling than the eight other peptide-receptor combinations due to AM2/IMD slow off-rate binding kinetics. The regions responsible for the slow off-rate were mapped to the AM2/IMD mid-region and the RAMP3 extracellular domain. MD simulations revealed how these bestow enhanced stability to the complex. Our results uncover AM2/IMD-AM(2)R as a cognate pair with unique temporal features, define the mechanism of kinetic selectivity, and explain how AM2/IMD and RAMP3 collaborate to shape the signaling output of a clinically important GPCR.
format Online
Article
Text
id pubmed-9882245
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-98822452023-01-28 Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin(2) G protein-coupled receptor Babin, Katie M. Karim, Jordan A. Gordon, Peyton H. Lennon, James Dickson, Alex Pioszak, Augen A. bioRxiv Article The signaling peptides adrenomedullin 2/intermedin (AM2/IMD), adrenomedullin (AM), and CGRP have overlapping and distinct functions in the cardiovascular, lymphatic, and nervous systems by activating three shared receptors comprised of the class B GPCR CLR in complex with a RAMP1, −2, or −3 modulatory subunit. Here, we report that AM2/IMD, which is thought to be a non-selective agonist, is kinetically selective for CLR-RAMP3, known as the AM(2)R. AM2/IMD-AM(2)R elicited substantially longer duration cAMP signaling than the eight other peptide-receptor combinations due to AM2/IMD slow off-rate binding kinetics. The regions responsible for the slow off-rate were mapped to the AM2/IMD mid-region and the RAMP3 extracellular domain. MD simulations revealed how these bestow enhanced stability to the complex. Our results uncover AM2/IMD-AM(2)R as a cognate pair with unique temporal features, define the mechanism of kinetic selectivity, and explain how AM2/IMD and RAMP3 collaborate to shape the signaling output of a clinically important GPCR. Cold Spring Harbor Laboratory 2023-01-13 /pmc/articles/PMC9882245/ /pubmed/36711519 http://dx.doi.org/10.1101/2023.01.13.523955 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Babin, Katie M.
Karim, Jordan A.
Gordon, Peyton H.
Lennon, James
Dickson, Alex
Pioszak, Augen A.
Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin(2) G protein-coupled receptor
title Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin(2) G protein-coupled receptor
title_full Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin(2) G protein-coupled receptor
title_fullStr Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin(2) G protein-coupled receptor
title_full_unstemmed Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin(2) G protein-coupled receptor
title_short Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin(2) G protein-coupled receptor
title_sort adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin(2) g protein-coupled receptor
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882245/
https://www.ncbi.nlm.nih.gov/pubmed/36711519
http://dx.doi.org/10.1101/2023.01.13.523955
work_keys_str_mv AT babinkatiem adrenomedullin2intermedinisaslowoffratelongactingendogenousagonistoftheadrenomedullin2gproteincoupledreceptor
AT karimjordana adrenomedullin2intermedinisaslowoffratelongactingendogenousagonistoftheadrenomedullin2gproteincoupledreceptor
AT gordonpeytonh adrenomedullin2intermedinisaslowoffratelongactingendogenousagonistoftheadrenomedullin2gproteincoupledreceptor
AT lennonjames adrenomedullin2intermedinisaslowoffratelongactingendogenousagonistoftheadrenomedullin2gproteincoupledreceptor
AT dicksonalex adrenomedullin2intermedinisaslowoffratelongactingendogenousagonistoftheadrenomedullin2gproteincoupledreceptor
AT pioszakaugena adrenomedullin2intermedinisaslowoffratelongactingendogenousagonistoftheadrenomedullin2gproteincoupledreceptor